ICCC
#3984
ImmuCell Corporation - Common Stock
11.0 8 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.74%
Variación mensual
+15.54%
Variación en los últimos 6 meses
+66.37%
Cambio anual
+71.25%
Cierres anteriores
10.8 9
Open
11.0 8
Mínimo
11.0 8
High
11.0 8
Volumen
1
Financials
- Market Capitalization 100.24 M
- Employee 73
- Founded 1982
- CEO Michael F Brigham
- Website www.immucell.com
- Headquarter Delaware, United States
- FIGI BBG000BLQ5Q2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.25
Relación precio/flujo de caja
2.01
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3970 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.06 USD | 0.00% | +0.99% | +19.07% | -4.97% | 104.11 M USD | ||
| 3976 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.92 USD | -5.43% | -1.66% | +2.07% | -1.66% | 101.70 M USD | ||
| 3998 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.33 USD | +0.76% | -2.92% | +10.83% | -31.79% | 96.16 M USD | ||
| 3999 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.16 USD | -1.69% | 0.00% | +3.57% | -15.33% | 95.44 M USD |